Carbamazepine Tablet, Extended Release
Product Images NDC 59746-790

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 59746-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbamazepine Extended-release Tablets Usp, 100 mg (NDC 59746-789-01)

This is a description for a medication called Carbamazepine in the form of coated tablets. Each tablet has a National Drug Code (NDC) of 59746-789-01 and is manufactured by Umedica Laboratories Pvt. Ltd. The packaging insert contains dosing information and the tablets are extended-release. Storage temperature is recommended between 20°C to 25°C (68°F to 77°F). The medication is distributed by Jubilant Cadista Pharmaceuticals Inc. and comes in a container with instructions to keep the tablets dry, dispense in a tight container, and away from children.*

FDA Label Image

Carbamazepine Extended-release Tablets Usp, 200 mg (NDC 59746-790-01)

This is a description of Carbamazepine USP extended-release tablets manufactured by Umedica Laboratories Pvt. Ltd in India and distributed by Jubilant Cadista Pharmaceuticals Inc. in the USA. The tablets contain 200 mg of carbamazepine and are to be swallowed whole, not crushed or chewed. Dosage information is available in the package insert, and the tablets should be kept in a tight container protected from moisture. They should be stored between 20°C and 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F) and kept out of reach of children. The NDC number is 59746-790-01.*

FDA Label Image

Carbamazepine Extended-release Tablets Usp, 400 mg- Ndc 59746-791-01 (100's Bottle Label)

Each tablet of Cadista's Carbamazepine Extended-Release contains 400 mg of Carbamazepine USP. It is important to swallow the tablet whole and never crush or chew it. Dosage details can be found in the package insert. This medication must be stored between 20°C to 25°C, with excursions permitted between 15°C and 30°C. Protect it from moisture and keep it out of the reach of children. It should be dispensed in a tight container along with the Medication Guide attached or provided separately. The product is manufactured by Umedica Laboratories Put. Ltd. in Vapi, India, and distributed by Jubilant Cadista Pharmaceuticals Inc. in Salisbury, USA.*

FDA Label Image

Image Description (Carbamazepine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.